{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:59:39Z","timestamp":1789642779064,"version":"4.0.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Polypharmacy is a significant concern for older adults. Taking multiple medicines to prevent and treat comorbidities is very common in older adults, potentially leading to polypharmacy. Polypharmacy is associated with the development of geriatric syndromes, including cognitive impairment, delirium, falls, frailty, urinary incontinence, and weight loss. The prevalence of polypharmacy varies according to the literature. There is a paucity of data regarding the prevalence of polypharmacy among older adults. Therefore, this study aimed to estimate the pooled prevalence of polypharmacy among older adults in Ethiopia. A comprehensive search of databases, including PubMed, MEDLINE, EMBASE, Hinari, Cumulative Index to Nursing and Allied Health Literature, International Scientific Indexing, Cochrane library and Web of Science, and Google Scholar, was conducted. STATA statistical software (version 17) was used to analyze the data. Forest plot and I<jats:sup>2<\/jats:sup> heterogeneity test were computed to examine the existence of heterogeneity. Subgroup analysis and sensitivity analysis were done to explore the source of heterogeneity. Publication bias was evaluated by using funnel plots and Egger\u2019s test. A random effect model was used to determine the pooled prevalence of polypharmacy. After reviewing 123 studies, 13 studies with a total of 3547 older adults fulfilled the inclusion criteria and were included in this meta-analysis. The result from 13 studies revealed that the pooled prevalence of polypharmacy among older adults in Ethiopia was 37.10% (95CI: 28.28\u201345.91). A Subgroup Meta-analysis showed that the heterogeneity level was slightly lower among studies done in Oromia region (I2\u2009=\u200946.62, P-value\u2009=\u20090.154). Higher pooled polypharmacy prevalence was found among older adults with cardiovascular disorders (42.7%) and admitted patients (51.4%). In general, it was found that the pooled prevalence of polypharmacy among older adults in Ethiopia was high. More than one in three older adults take five or more medications at a time. Thus, intervention focusing on rational geriatric pharmacotherapy is significant to prevent unnecessary pill burden, adverse drug events, medical costs, geriatric morbidity, and mortality. Furthermore, enhancing pharmacist roles towards medication therapy management and safety monitoring in older adults is also indicated.<\/jats:p>","DOI":"10.1038\/s41598-023-45095-2","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T11:03:16Z","timestamp":1697540596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence of polypharmacy among older adults in Ethiopia: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"13","author":[{"given":"Tegene Atamenta","family":"kitaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ribka Nigatu","family":"Haile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"45095_CR1","doi-asserted-by":"publisher","first-page":"CD008165","DOI":"10.1002\/14651858.CD008165.pub3","volume":"10","author":"SM Patterson","year":"2014","unstructured":"Patterson, S. M. et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst. Rev. 10, CD008165. https:\/\/doi.org\/10.1002\/14651858.CD008165.pub3 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"45095_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/NHH.0b013e31826502dd","volume":"30","author":"GI Riker","year":"2012","unstructured":"Riker, G. I. & Setter, S. M. Polypharmacy in older adults at home: What it is and what to do about it\u2014implications for home healthcare and hospice. Home Healthcare Now. 30(8), 474\u2013485 (2012).","journal-title":"Home Healthcare Now."},{"key":"45095_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-244x-4-18","volume":"4","author":"C De-las-Cuevas","year":"2004","unstructured":"De-las-Cuevas, C. & Sanz, E. J. Polypharmacy in psychiatric practice in the Canary Islands. BMC Psychiatry. 4, 18. https:\/\/doi.org\/10.1186\/1471-244x-4-18 (2004).","journal-title":"BMC Psychiatry."},{"issue":"6","key":"45095_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00228-015-1837-8","volume":"71","author":"J D\u00edez-Manglano","year":"2015","unstructured":"D\u00edez-Manglano, J. et al. Excessive polypharmacy and survival in polypathological patients. Eur. J. Clin. Pharmacol. 71(6), 733\u2013739. https:\/\/doi.org\/10.1007\/s00228-015-1837-8 (2015).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"45095_CR5","unstructured":"Jiron, M. et al. Prevalence of potentially inappropriate medication prescribing among older adults in emergency Department in Chile. In Pharmacoepidemiology and Drug Safety (Wiley, 2015)."},{"issue":"1","key":"45095_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon, N., Shakib, S., Kalisch-Ellett, L. & Caughey, G. E. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 17(1), 230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2 (2017).","journal-title":"BMC Geriatr."},{"key":"45095_CR7","doi-asserted-by":"publisher","first-page":"204209862093374","DOI":"10.1177\/2042098620933741","volume":"11","author":"M Khezrian","year":"2020","unstructured":"Khezrian, M., McNeil, C. J., Murray, A. D. & Myint, P. K. An overview of prevalence, determinants and health outcomes of polypharmacy. Therapeut. Adv. Drug Saf. 11, 2042098620933741. https:\/\/doi.org\/10.1177\/2042098620933741 (2020).","journal-title":"Therapeut. Adv. Drug Saf."},{"issue":"3","key":"45095_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","volume":"12","author":"F Pazan","year":"2021","unstructured":"Pazan, F. & Wehling, M. Polypharmacy in older adults: A narrative review of definitions, epidemiology and consequences. Eur. Geriatr. Med. 12(3), 443\u2013452. https:\/\/doi.org\/10.1007\/s41999-021-00479-3 (2021).","journal-title":"Eur. Geriatr. Med."},{"key":"45095_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2018.05.002","volume":"101","author":"N Abolhassani","year":"2018","unstructured":"Abolhassani, N. & Marques-Vidal, P. Polypharmacy, defined as taking five or more drugs, is inadequate in the cardiovascular setting. J. Clin. Epidemiol. 101, 1\u20134. https:\/\/doi.org\/10.1016\/j.jclinepi.2018.05.002 (2018).","journal-title":"J. Clin. Epidemiol."},{"issue":"6","key":"45095_CR10","first-page":"i","volume":"6","author":"RJ Dagli","year":"2014","unstructured":"Dagli, R. J. & Sharma, A. Polypharmacy: A global risk factor for elderly people. J. Int. Oral Health. 6(6), i\u2013ii (2014).","journal-title":"J. Int. Oral Health."},{"key":"45095_CR11","unstructured":"Sherman, J. J., Davis, L., Daniels, K. Addressing the polypharmacy conundrum. US Pharm. 42(6), 14\u201320 (2017)."},{"issue":"11","key":"45095_CR12","doi-asserted-by":"publisher","first-page":"e112133","DOI":"10.1371\/journal.pone.0112133","volume":"9","author":"B Ahmed","year":"2014","unstructured":"Ahmed, B., Nanji, K., Mujeeb, R. & Patel, M. J. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: A prospective cohort study. PLoS One. 9(11), e112133. https:\/\/doi.org\/10.1371\/journal.pone.0112133 (2014).","journal-title":"PLoS One."},{"key":"45095_CR13","first-page":"7","volume":"6","author":"A Romana","year":"2012","unstructured":"Romana, A., Kamath, L., Sarda, A., Muraraiah, S. & Cr, J. Polypharmacy leading to adverse drug reactions in elderly in a tertiary care hospital. Mortality. 6, 7 (2012).","journal-title":"Mortality."},{"key":"45095_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fpubh.2017.00335","volume":"5","author":"E Jaul","year":"2017","unstructured":"Jaul, E. & Barron, J. Age-related diseases and clinical and public health implications for the 85 years old and over population. Front. Public Health. 5, 335. https:\/\/doi.org\/10.3389\/fpubh.2017.00335 (2017).","journal-title":"Front. Public Health."},{"issue":"9","key":"45095_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40266-016-0387-9","volume":"33","author":"A Marengoni","year":"2016","unstructured":"Marengoni, A. et al. Strategies to improve medication adherence in older persons: Consensus statement from the senior italia federanziani advisory board. Drugs Aging. 33(9), 629\u2013637. https:\/\/doi.org\/10.1007\/s40266-016-0387-9 (2016).","journal-title":"Drugs Aging."},{"issue":"10","key":"45095_CR16","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/jhm.2614","volume":"11","author":"AA Saraf","year":"2016","unstructured":"Saraf, A. A. et al. Medications associated with geriatric syndromes and their prevalence in older hospitalized adults discharged to skilled nursing facilities. J. Hosp. Med. 11(10), 694\u2013700. https:\/\/doi.org\/10.1002\/jhm.2614 (2016).","journal-title":"J. Hosp. Med."},{"issue":"1","key":"45095_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1186\/s12877-022-03536-z","volume":"22","author":"L Ye","year":"2022","unstructured":"Ye, L. et al. Factors associated with polypharmacy and the high risk of medication-related problems among older community-dwelling adults in European countries: A longitudinal study. BMC Geriatr. 22(1), 841. https:\/\/doi.org\/10.1186\/s12877-022-03536-z (2022).","journal-title":"BMC Geriatr."},{"issue":"9","key":"45095_CR18","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","volume":"65","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic, D. et al. Polypharmacy cutoff and outcomes: Five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J. Clin. Epidemiol. 65(9), 989\u2013995. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.02.018 (2012).","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"45095_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.amjopharm.2010.03.005","volume":"8","author":"M Akazawa","year":"2010","unstructured":"Akazawa, M., Imai, H., Igarashi, A. & Tsutani, K. Potentially inappropriate medication use in elderly Japanese patients. Am. J. Geriatr. Pharmacother. 8(2), 146\u2013160. https:\/\/doi.org\/10.1016\/j.amjopharm.2010.03.005 (2010).","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"45095_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12916-015-0322-7","volume":"13","author":"B Guthrie","year":"2015","unstructured":"Guthrie, B., Makubate, B., Hernandez-Santiago, V. & Dreischulte, T. The rising tide of polypharmacy and drug-drug interactions: Population database analysis 1995\u20132010. BMC Med. 13, 74. https:\/\/doi.org\/10.1186\/s12916-015-0322-7 (2015).","journal-title":"BMC Med."},{"issue":"5","key":"45095_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.therap.2019.10.001","volume":"75","author":"J Guillot","year":"2020","unstructured":"Guillot, J., Maumus-Robert, S. & Bezin, J. Polypharmacy: A general review of definitions, descriptions and determinants. Therapie 75(5), 407\u2013416. https:\/\/doi.org\/10.1016\/j.therap.2019.10.001 (2020).","journal-title":"Therapie"},{"key":"45095_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.archger.2018.06.018","volume":"78","author":"L Mid\u00e3o","year":"2018","unstructured":"Mid\u00e3o, L., Giardini, A., Menditto, E., Kardas, P. & Costa, E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch. Gerontol. Geriatr. 78, 213\u2013220. https:\/\/doi.org\/10.1016\/j.archger.2018.06.018 (2018).","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"3","key":"45095_CR23","doi-asserted-by":"publisher","first-page":"e0194892","DOI":"10.1371\/journal.pone.0194892","volume":"13","author":"JW Wastesson","year":"2018","unstructured":"Wastesson, J. W., Cedazo Minguez, A., Fastbom, J., Maioli, S. & Johnell, K. The composition of polypharmacy: A register-based study of Swedes aged 75 years and older. PLoS One. 13(3), e0194892. https:\/\/doi.org\/10.1371\/journal.pone.0194892 (2018).","journal-title":"PLoS One."},{"issue":"2","key":"45095_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5694\/mja2.50244","volume":"211","author":"AT Page","year":"2019","unstructured":"Page, A. T., Falster, M. O., Litchfield, M., Pearson, S. A. & Etherton-Beer, C. Polypharmacy among older Australians, 2006\u20132017: A population-based study. Med. J. Aust. 211(2), 71\u201375. https:\/\/doi.org\/10.5694\/mja2.50244 (2019).","journal-title":"Med. J. Aust."},{"issue":"1","key":"45095_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13690-015-0095-7","volume":"73","author":"D Walckiers","year":"2015","unstructured":"Walckiers, D., Van der Heyden, J. & Tafforeau, J. Factors associated with excessive polypharmacy in older people. Arch. Public Health. 73(1), 1\u201312. https:\/\/doi.org\/10.1186\/s13690-015-0095-7 (2015).","journal-title":"Arch. Public Health."},{"issue":"1","key":"45095_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-018-0754-y","volume":"18","author":"X Lai","year":"2018","unstructured":"Lai, X., Zhu, H., Huo, X. & Li, Z. Polypharmacy in the oldest old (\u2265 80 years of age) patients in China: A cross-sectional study. BMC Geriatr. 18(1), 1\u20138. https:\/\/doi.org\/10.1186\/s12877-018-0754-y (2018).","journal-title":"BMC Geriatr."},{"issue":"1","key":"45095_CR27","first-page":"85","volume":"7","author":"M Shalini","year":"2012","unstructured":"Shalini, M. & Joshi, M. Study of polypharmacy and associated problems among elderly patients. Internet J. Med. Update-EJ. 7(1), 85 (2012).","journal-title":"Internet J. Med. Update-EJ."},{"issue":"3","key":"45095_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jsps.2022.01.003","volume":"30","author":"MH Aljawadi","year":"2022","unstructured":"Aljawadi, M. H. et al. Prevalence of polypharmacy and factors associated with it among Saudi older adults-results from the Saudi national survey for Elderly Health (SNSEH). Saudi Pharmaceut. J. 30(3), 230\u2013236. https:\/\/doi.org\/10.1016\/j.jsps.2022.01.003 (2022).","journal-title":"Saudi Pharmaceut. J."},{"issue":"1","key":"45095_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2139\/ssrn.3508232","volume":"29","author":"W Akande-Sholabi","year":"2018","unstructured":"Akande-Sholabi, W., Adebusoye, L. & Olowookere, O. Polypharmacy and factors associated with their prevalence among older patients attending a geriatric centre in South-West Nigeria. West Afr. J. Pharm. 29(1), 35\u201345. https:\/\/doi.org\/10.2139\/ssrn.3508232 (2018).","journal-title":"West Afr. J. Pharm."},{"key":"45095_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1155\/2022\/8742998","volume":"2022","author":"SB Dagnew","year":"2022","unstructured":"Dagnew, S. B., Binega Mekonnen, G., Gebeye Zeleke, E., Agegnew Wondm, S. & Yimer, T. T. Clinical pharmacist intervention on drug-related problems among elderly patients admitted to medical wards of Northwest Ethiopia comprehensive specialized hospitals: A multicenter prospective, observational study. BioMed. Res. Int. 2022, 89. https:\/\/doi.org\/10.1155\/2022\/8742998 (2022).","journal-title":"BioMed. Res. Int."},{"issue":"11","key":"45095_CR31","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.4314\/tjpr.v19i11.27","volume":"19","author":"W Lemma","year":"2020","unstructured":"Lemma, W., Islam, M. & Loha, E. Potentially inappropriate medication prescribing patterns in geriatric patients in a health facility in Addis Ababa, Ethiopia. Trop. J. Pharmaceut. Res. 19(11), 2441\u20132446. https:\/\/doi.org\/10.4314\/tjpr.v19i11.27 (2020).","journal-title":"Trop. J. Pharmaceut. Res."},{"key":"45095_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/iprp.S231286","volume":"9","author":"YA Assefa","year":"2020","unstructured":"Assefa, Y. A., Kedir, A. & Kahaliw, W. Survey on polypharmacy and drug-drug interactions among elderly people with cardiovascular diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia. Integr. Pharm. Res. Pract. 9, 1\u20139. https:\/\/doi.org\/10.2147\/iprp.S231286 (2020).","journal-title":"Integr. Pharm. Res. Pract."},{"issue":"6","key":"45095_CR33","doi-asserted-by":"publisher","first-page":"e0234000","DOI":"10.1371\/journal.pone.0234000","volume":"15","author":"YG Tefera","year":"2020","unstructured":"Tefera, Y. G., Alemayehu, M. & Mekonnen, G. B. Prevalence and determinants of polypharmacy in cardiovascular patients attending outpatient clinic in Ethiopia University Hospital. PLoS One 15(6), e0234000. https:\/\/doi.org\/10.1371\/journal.pone.0234000 (2020).","journal-title":"PLoS One"},{"issue":"9","key":"45095_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/ph14090844","volume":"14","author":"AS Bhagavathula","year":"2021","unstructured":"Bhagavathula, A. S. et al. Prevalence and determinants of multimorbidity, polypharmacy, and potentially inappropriate medication use in the older outpatients: Findings from EuroAgeism H2020 ESR7 Project in Ethiopia. Pharmaceut. (Basel). 14(9), 74. https:\/\/doi.org\/10.3390\/ph14090844 (2021).","journal-title":"Pharmaceut. (Basel)."},{"issue":"3","key":"45095_CR35","doi-asserted-by":"publisher","first-page":"e0214191","DOI":"10.1371\/journal.pone.0214191","volume":"14","author":"HG Tegegn","year":"2019","unstructured":"Tegegn, H. G. et al. Medication-related quality of life among Ethiopian elderly patients with polypharmacy: A cross-sectional study in an Ethiopia university hospital. PLoS One. 14(3), e0214191. https:\/\/doi.org\/10.1371\/journal.pone.0214191 (2019).","journal-title":"PLoS One."},{"key":"45095_CR36","first-page":"1","volume":"6","author":"M Alebachew","year":"2016","unstructured":"Alebachew, M., Tileku, M. & Beyene, A. The position of clinical pharmacists in delivering advanced pharmacy practice education and services: Short communication. Clin. Exp. Pharmacol. 6, 1\u20135 (2016).","journal-title":"Clin. Exp. Pharmacol."},{"key":"45095_CR37","unstructured":"EFDA. Standard Treatment Guidelines for General Hospitals, Ethiopia. Third Edition: Ethiopian Food and Drug Authority (2014)."},{"issue":"1","key":"45095_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher, D. et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 4(1), 1. https:\/\/doi.org\/10.1186\/2046-4053-4-1 (2015).","journal-title":"Syst. Rev."},{"issue":"1","key":"45095_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12874-018-0495-9","volume":"18","author":"M Mueller","year":"2018","unstructured":"Mueller, M. et al. Methods to systematically review and meta-analyse observational studies: A systematic scoping review of recommendations. BMC Med. Res. Methodol. 18(1), 44. https:\/\/doi.org\/10.1186\/s12874-018-0495-9 (2018).","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"45095_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12874-017-0468-4","volume":"18","author":"Z Munn","year":"2018","unstructured":"Munn, Z., Stern, C., Aromataris, E., Lockwood, C. & Jordan, Z. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med. Res. Methodol. 18(1), 5. https:\/\/doi.org\/10.1186\/s12874-017-0468-4 (2018).","journal-title":"BMC Med. Res. Methodol."},{"issue":"15","key":"45095_CR41","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 283(15), 2008\u20132012. https:\/\/doi.org\/10.1001\/jama.283.15.2008 (2000).","journal-title":"JAMA."},{"issue":"1","key":"45095_CR42","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/jep.13159","volume":"26","author":"L Lin","year":"2020","unstructured":"Lin, L. Comparison of four heterogeneity measures for meta-analysis. J Eval Clin Pract. 26(1), 376\u2013384. https:\/\/doi.org\/10.1111\/jep.13159 (2020).","journal-title":"J Eval Clin Pract."},{"issue":"4","key":"45095_CR43","doi-asserted-by":"publisher","first-page":"e020590","DOI":"10.1136\/bmjopen-2017-020590","volume":"8","author":"HG Tegegn","year":"2018","unstructured":"Tegegn, H. G. et al. Older patients\u2019 perception of deprescribing in resource-limited settings: A cross-sectional study in an Ethiopia university hospital. BMJ Open 8(4), e020590 (2018).","journal-title":"BMJ Open"},{"key":"45095_CR44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1159\/000516075","volume":"17","author":"L Adem","year":"2022","unstructured":"Adem, L. & Tegegne, G. T. Medication appropriateness, polypharmacy, and drug-drug interactions in ambulatory elderly patients with cardiovascular diseases at Tikur Anbessa Specialized Hospital, Ethiopia. Clin. Interv. Aging 17, 509\u2013517. https:\/\/doi.org\/10.1159\/000516075 (2022).","journal-title":"Clin. Interv. Aging"},{"issue":"1","key":"45095_CR45","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s13104-016-2238-5","volume":"21","author":"BT Tesfaye","year":"2021","unstructured":"Tesfaye, B. T., Tessema, M. T., Yizengaw, M. A. & Bosho, D. D. Potentially inappropriate medication use among older adult patients on follow-up at the chronic care clinic of a specialized teaching hospital in Ethiopia. A cross-sectional study. BMC Geriatr. 21(1), 530. https:\/\/doi.org\/10.1186\/s13104-016-2238-5 (2021).","journal-title":"BMC Geriatr."},{"key":"45095_CR46","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4172\/1948-593X.1000193","volume":"9","author":"G Geresu","year":"2017","unstructured":"Geresu, G., Yadesa, T. & Abebe, B. Polypharmacy and the contributing factors among elderly patients in shashemene referral hospital, West Arsi, Oromia Region, Ethiopia. J. Bioanal. Biomed. 9, 277\u2013282. https:\/\/doi.org\/10.4172\/1948-593X.1000193 (2017).","journal-title":"J. Bioanal. Biomed."},{"issue":"1","key":"45095_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-016-2238-5","volume":"9","author":"F Teka","year":"2016","unstructured":"Teka, F., Teklay, G., Ayalew, E. & Teshome, T. Potential drug\u2013drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: A cross sectional study. BMC Res. Notes. 9(1), 1\u20138 (2016).","journal-title":"BMC Res. Notes."},{"issue":"1","key":"45095_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-020-1413-7","volume":"20","author":"BY Hailu","year":"2020","unstructured":"Hailu, B. Y., Berhe, D. F., Gudina, E. K., Gidey, K. & Getachew, M. Drug related problems in admitted geriatric patients: The impact of clinical pharmacist interventions. BMC Geriatr. 20(1), 1\u20138. https:\/\/doi.org\/10.1186\/s12877-020-1413-7 (2020).","journal-title":"BMC Geriatr."},{"key":"45095_CR49","unstructured":"Solomon M MGEM. Assessment of Prevalence and Associated Factors of Polypharmacy among Elderly Patients Admitted to Federal Police Referral Hospital, Addis Ababa, Ethiopia. http:\/\/etd.aau.edu.et\/handle\/123456789\/28702 (2021)."},{"issue":"15","key":"45095_CR50","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5897\/AJPP2017.4736","volume":"11","author":"O Sada","year":"2017","unstructured":"Sada, O. Irrational use of medications among elderly patients in an Ethiopian referral hospital. Afr. J. Pharm. Pharmacol. 11(15), 191\u2013194. https:\/\/doi.org\/10.5897\/AJPP2017.4736 (2017).","journal-title":"Afr. J. Pharm. Pharmacol."},{"issue":"9","key":"45095_CR51","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","volume":"271","author":"GA Colditz","year":"2004","unstructured":"Colditz, G. A. et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. Jama 271(9), 698\u2013702 (2004).","journal-title":"Jama"},{"key":"45095_CR52","doi-asserted-by":"publisher","first-page":"862561","DOI":"10.3389\/fphar.2022.862561","volume":"13","author":"F Tian","year":"2022","unstructured":"Tian, F., Chen, Z. & Wu, J. Prevalence of polypharmacy and potentially inappropriate medications use in elderly chinese patients: A systematic review and meta-analysis. Front. Pharmacol. 13, 862561. https:\/\/doi.org\/10.3389\/fphar.2022.862561 (2022).","journal-title":"Front. Pharmacol."},{"key":"45095_CR53","doi-asserted-by":"publisher","first-page":"685518","DOI":"10.3389\/fphar.2021.685518","volume":"12","author":"AS Bhagavathula","year":"2021","unstructured":"Bhagavathula, A. S. et al. Prevalence of polypharmacy, hyperpolypharmacy and potentially inappropriate medication use in older adults in India: A systematic review and meta-analysis. Front. Pharmacol. 12, 685518. https:\/\/doi.org\/10.3389\/fphar.2021.685518 (2021).","journal-title":"Front. Pharmacol."},{"key":"45095_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/bmjgh-2022-008880","volume":"7","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Community prevalence and dyad disease pattern of multimorbidity in China and India: A systematic review. BMJ Glob. Health 7, 9. https:\/\/doi.org\/10.1136\/bmjgh-2022-008880 (2022).","journal-title":"BMJ Glob. Health"},{"issue":"3","key":"45095_CR55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000368191","volume":"61","author":"PS Nishtala","year":"2015","unstructured":"Nishtala, P. S. & Salahudeen, M. S. Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005\u20132013. Gerontology 61(3), 195\u2013202. https:\/\/doi.org\/10.1159\/000368191 (2015).","journal-title":"Gerontology"},{"key":"45095_CR56","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/pharmacy7020033","volume":"7","author":"S Assari","year":"2019","unstructured":"Assari, S., Helmi, H. & Bazargan, M. Polypharmacy in African American adults: A national epidemiological study. Pharm. (Basel). 7, 2. https:\/\/doi.org\/10.3390\/pharmacy7020033 (2019).","journal-title":"Pharm. (Basel)."},{"issue":"2","key":"45095_CR57","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000516075","volume":"68","author":"AS Bhagavathula","year":"2022","unstructured":"Bhagavathula, A. S., Gebreyohannes, E. A. & Fialova, D. Prevalence of polypharmacy and risks of potentially inappropriate medication use in the older population in a developing country: A systematic review and meta-analysis. Gerontology 68(2), 136\u2013145. https:\/\/doi.org\/10.1159\/000516075 (2022).","journal-title":"Gerontology"},{"key":"45095_CR58","doi-asserted-by":"publisher","first-page":"205031212110390","DOI":"10.1177\/20503121211039099","volume":"9","author":"TM Yadesa","year":"2021","unstructured":"Yadesa, T. M. et al. Prevalence, characteristics and predicting risk factors of adverse drug reactions among hospitalized older adults: A systematic review and meta-analysis. SAGE Open Med. 9, 20503121211039100. https:\/\/doi.org\/10.1177\/20503121211039099 (2021).","journal-title":"SAGE Open Med."},{"issue":"11","key":"45095_CR59","doi-asserted-by":"publisher","first-page":"e006977","DOI":"10.1161\/circheartfailure.120.006977","volume":"13","author":"O Unlu","year":"2020","unstructured":"Unlu, O. et al. Polypharmacy in older adults hospitalized for heart failure. Circ. Heart Fail. 13(11), e006977. https:\/\/doi.org\/10.1161\/circheartfailure.120.006977 (2020).","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"45095_CR60","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.amjopharm.2010.06.004","volume":"8","author":"A Harugeri","year":"2010","unstructured":"Harugeri, A., Joseph, J., Parthasarathi, G., Ramesh, M. & Guido, S. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: A prospective surveillance study from two teaching hospitals in India. Am. J. Geriatr. Pharmacother. 8(3), 271\u2013280. https:\/\/doi.org\/10.1016\/j.amjopharm.2010.06.004 (2010).","journal-title":"Am. J. Geriatr. Pharmacother."},{"issue":"2","key":"45095_CR61","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejheart.2003.09.009","volume":"6","author":"M Mart\u00ednez-Sell\u00e9s","year":"2004","unstructured":"Mart\u00ednez-Sell\u00e9s, M. et al. Pharmacological treatment in patients with heart failure: Patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations. Eur. J. Heart Fail. 6(2), 219\u2013226. https:\/\/doi.org\/10.1016\/j.ejheart.2003.09.009 (2004).","journal-title":"Eur. J. Heart Fail."},{"key":"45095_CR62","unstructured":"World Health Organization. Ageing and Health. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ageing-and-health (2022)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45095-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45095-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45095-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T13:26:26Z","timestamp":1700486786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45095-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["45095"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-45095-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"24 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17641"}}